Literature DB >> 2111980

Nebulised sodium cromoglycate in infancy: airway protection after deterioration.

C O'Callaghan1, A D Milner, A Swarbrick.   

Abstract

Over a two year period 100 infants with histories of wheeze were challenged with nebulised water. They were sedated and lung function measured by total body plethysmography. Thirteen of the 53 infants who developed bronchoconstriction after challenge with nebulised water were given nebulised sodium cromoglycate and rechallenged with nebulised water. All infants were initially challenged with normal saline, after which there was no significant change in lung function. After challenge with nebulised water and sodium cromoglycate there were significant decreases in specific conductance compared with those found after challenge with normal saline. After rechallenge with nebulised water there was no deterioration in lung function. Although sodium cromoglycate caused a deterioration in lung function in these infants, it protected their airways from challenge with nebulised water.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2111980      PMCID: PMC1792202          DOI: 10.1136/adc.65.4.404

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  9 in total

1.  Mediators of hypersensitivity and "fog"-induced asthma.

Authors:  R J Shaw; S D Anderson; S R Durham; K M Taylor; R E Schoeffel; W Green; P Torzillo; A B Kay
Journal:  Allergy       Date:  1985-01       Impact factor: 13.146

2.  Measurement of airway resistance and thoracic gas volume in infancy.

Authors:  M Radford
Journal:  Arch Dis Child       Date:  1974-08       Impact factor: 3.791

3.  Bronchodilator effect of sodium cromoglycate and its clinical implications.

Authors:  J T Chung; R S Jones
Journal:  Br Med J       Date:  1979-10-27

4.  Nebulised ipratropium bromide and sodium cromoglycate in the first two years of life.

Authors:  R L Henry; E J Hiller; A D Milner; I G Hodges; G M Stokes
Journal:  Arch Dis Child       Date:  1984-01       Impact factor: 3.791

5.  Nebulised sodium cromoglycate in the treatment of wheezy bronchitis in infants and young children.

Authors:  C Geller-Bernstein; S Levin
Journal:  Respiration       Date:  1982       Impact factor: 3.580

6.  Evaluation of ultrasonically nebulised solutions for provocation testing in patients with asthma.

Authors:  S D Anderson; R E Schoeffel; M Finney
Journal:  Thorax       Date:  1983-04       Impact factor: 9.139

7.  Isotonic nebulized disodium cromoglycate provides better protection against methacholine- and exercise-induced bronchoconstriction.

Authors:  P Weiner; M Saaid; A Reshef
Journal:  Am Rev Respir Dis       Date:  1988-06

8.  Pulmonary epithelial permeability after inhaling saline, distilled water "fog" and cold air.

Authors:  C Borland; A Chamberlain; B Barber; T Higenbottam
Journal:  Chest       Date:  1985-03       Impact factor: 9.410

9.  Nebulised salbutamol does have a protective effect on airways in children under 1 year old.

Authors:  C O'Callaghan; A D Milner; A Swarbrick
Journal:  Arch Dis Child       Date:  1988-05       Impact factor: 3.791

  9 in total
  2 in total

Review 1.  Nebuliser therapy in childhood.

Authors:  P W Barry; C O'Callaghan
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

2.  The effect of sodium cromoglycate on upper and lower respiratory symptoms in children born prematurely.

Authors:  B Yuksel; A Greenough
Journal:  Eur J Pediatr       Date:  1993-07       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.